Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000674367 | SCV000799691 | pathogenic | Xeroderma pigmentosum, group C | 2018-04-30 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001855606 | SCV002234367 | pathogenic | not provided | 2023-11-15 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu763Cysfs*4) in the XPC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in XPC are known to be pathogenic (PMID: 23173980, 25256075). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of xeroderma pigmentosum (PMID: 20054342, 26278556). ClinVar contains an entry for this variant (Variation ID: 558141). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000674367 | SCV004206985 | pathogenic | Xeroderma pigmentosum, group C | 2023-07-20 | criteria provided, single submitter | clinical testing |